| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Monivent AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.44 |
| 52 Week High | kr3.85 |
| 52 Week Low | kr0.27 |
| Beta | 0.84 |
| 1 Month Change | -10.22% |
| 3 Month Change | 18.65% |
| 1 Year Change | -83.56% |
| 3 Year Change | -95.09% |
| 5 Year Change | n/a |
| Change since IPO | -89.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| MONI | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.2% | -4.4% | 0.6% |
| 1Y | -83.6% | -9.4% | 16.0% |
Return vs Industry: MONI underperformed the Swedish Medical Equipment industry which returned -9.4% over the past year.
Return vs Market: MONI underperformed the Swedish Market which returned 16% over the past year.
Price Volatility
| MONI volatility | |
|---|---|
| MONI Average Weekly Movement | 23.4% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 13.2% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: MONI's share price has been volatile over the past 3 months.
Volatility Over Time: MONI's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 8 | Maria Lindqvist | www.monivent.se |
Monivent AB operates as a medtech company in Sweden. It offers Monivent Neo100, a medical device providing ventilation for newborns in need of respiratory support at birth; and Monivent Neo Training for the use of ventilation training on manikins. The company was incorporated in 2013 and is based in Gothenburg, Sweden.
Monivent AB Fundamentals Summary
| MONI fundamental statistics | |
|---|---|
| Market cap | kr14.16m |
| Earnings (TTM) | -kr13.00m |
| Revenue (TTM) | kr3.62m |
3.9x
P/S Ratio-1.1x
P/E RatioIs MONI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MONI income statement (TTM) | |
|---|---|
| Revenue | kr3.62m |
| Cost of Revenue | kr1.53m |
| Gross Profit | kr2.09m |
| Other Expenses | kr15.09m |
| Earnings | -kr13.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.40 |
| Gross Margin | 57.83% |
| Net Profit Margin | -359.43% |
| Debt/Equity Ratio | 9.8% |
How did MONI perform over the long term?
See historical performance and comparison